Revenue (Quarterly) Chart

View Revenue (Quarterly) for LGMK.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue (Quarterly) Chart
Start Trial

Historical Revenue (Quarterly) Data

View and export this data back to 2012. Start Trial.
Date Value
June 30, 2026 3.349M
March 31, 2026 3.214M
December 31, 2025 3.065M
September 30, 2025 2.915M
June 30, 2025 2.853M
March 31, 2025 2.592M
December 31, 2024 2.249M
September 30, 2024 2.706M
June 30, 2024 2.336M
March 31, 2024 2.611M
December 31, 2023 2.426M
September 30, 2023 2.367M
June 30, 2023 2.327M
March 31, 2023 2.810M
December 31, 2022 2.146M
September 30, 2022 2.752M
June 30, 2022 3.368M
March 31, 2022 3.651M
December 31, 2021 2.418M
September 30, 2021 2.383M
June 30, 2021 2.783M
March 31, 2021 2.439M
December 31, 2020 2.577M
September 30, 2020 2.639M
June 30, 2020 2.483M
Date Value
March 31, 2020 3.744M
December 31, 2019 4.024M
September 30, 2019 4.444M
June 30, 2019 4.487M
March 31, 2019 4.182M
December 31, 2018 4.034M
September 30, 2018 4.368M
June 30, 2018 4.378M
March 31, 2018 4.336M
December 31, 2017 4.356M
September 30, 2017 3.666M
June 30, 2017 7.656M
March 31, 2017 6.681M
December 31, 2016 4.562M
September 30, 2016 3.093M
June 30, 2016 0.0385M
March 31, 2016 0.0423M
December 31, 2015 0.0833M
September 30, 2015 0.4181M
June 30, 2015 0.1131M
March 31, 2015 0.0023M
December 31, 2014 0.00
September 30, 2014 0.00
June 30, 2014 0.00
March 31, 2014 0.00

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (Quarterly) Range, Past 5 Years

View Revenue (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (Quarterly) Benchmarks

View Revenue (Quarterly) Benchmarks
Start Trial
Abbott Laboratories 12.59B
Align Technology, Inc. 1.056B
AngioDynamics, Inc. 86.61M
Accuray, Inc. 100.92M
Alphatec Holdings, Inc. 213.51M